A Michigan State University College of Human Medicine researcher has been awarded a federal grant to study a gene therapy treatment for cystic fibrosis, a potential cure for CF. The grant from the National Institutes of Health will allow a team of researchers led by Xiaopeng Li, PhD, an associate professor in the Department of Pediatrics and Human Development, to study how CFTR gene (the causal gene for cystic fibrosis) mutations in the small airways in the lungs of cystic fibrosis patients lead to life-threatening infections. Li will lead a team that includes College of Human Medicine researchers Jeremy Prokop, PhD and Christopher Waters, PhD. The team also includes four pulmonologists – Ryan Thomas, MD - from MSU College of Human Medicine and Reda Girgis, MD, Susan Millard, MD, and John Schuen, MD – from Spectrum Health and Helen DeVos Children’s Hospital Cystic Fibrosis Center.
More information below: